The Bahraini doctor says the questions that matter go beyond pounds lost: trial strength, efficacy, safety and which patients the pill suits.
Recap by typeshit. Post by Dr. Najla Mahmood Shamsi on Instagram.
Keltie Knight shares a personal take on body image pressure on women, tagged with GLP-1 and BookTok. It's a short social clip with few specifics.
8:41
The weekly tirzepatide update marks a milestone for the channel, with the scale finally dipping below 220 pounds.
Dr. Salas-Whalen makes the case that stepping down on a GLP-1 dose can be as important as going up. Her view, not a protocol.
A short link post on what patients should keep in mind as options for semaglutide and tirzepatide keep shifting. Details are at the source.
Lilly reports the combo changed 482 proteins versus 140 with Taltz alone by week 36, in a trial of 274 adults with psoriasis and obesity.
Cutchins walks through a possible link between GLP-1 receptors and mast cell stabilization, and where insulin resistance and blood sugar swings fit in.
Loading…